Stryker: Cyber Disruption Temporary, But Valuation Premium Persists

What happened

Stryker's Q1 miss was driven by a temporary cyber disruption, not demand weakness, and full-year guidance is unchanged, so the selloff appears overdone. However, the stock still trades at ~46x earnings, far above a DCF value of ~$124, with tariff headwinds and M&A integration risks remaining. The market may be giving too much credit for the disruption, but the underlying business quality and growth trajectory are intact. Investors should weigh the near-term buying opportunity against the lack of margin of safety at current levels.

Implication

If you believe Stryker can sustain double-digit growth and expand margins, the current dip is a buying opportunity. However, at 46x earnings, any growth disappointment could trigger severe multiple compression. For long-term holders, the premium valuation leaves little room for error, so a trim on strength may be prudent. A significant de-rating to more reasonable multiples would present a better entry.

Thesis delta

The article argues the market overreacted to a one-time cyber event, which is directionally correct, but the DeepValue report's structural concern about valuation and tariff risks remains unchanged. The thesis shifts slightly from 'Potential Sell' to 'Wait for better entry' as the short-term overreaction creates a tactical opportunity, but the fundamental overvaluation persists.